The AACR Annual Meeting is a globally renowned event organized by the American Association for Cancer Research (AACR), bringing together thousands of researchers, clinicians, and professionals from the oncology field. It is widely recognized as a leading forum for showcasing groundbreaking discoveries and advancements in cancer research, prevention, and treatment.
© 2025 GAKEPS
melayu

Kemas Kini Terkini
-
Neurotech’s ENCELTO: The First FDA-Approved Solution for MacTel PatientsIn a significant achievement for the ophthalmic field, Neurotech’s ENCELTO has earned FDA approval, becoming the first and only approved treatment for Macular Telangiectasia type 2 (MacTel). This groundbreaking therapy offers hope for patients suffering from this rare retinal condition, marking a turning point in the way MacTel is managed. What is Macular Telangiectasia (MacTel)?...0 Komen 0 Perkongsian 823 Views 0 reviewSila log masuk untuk suka komen dan kongsi!
-
Revolutionizing Mucopolysaccharidosis Type I Management: From Enzyme Therapy to Gene TherapyMucopolysaccharidosis type I (MPS I) is a rare metabolic disorder caused by a deficiency in the enzyme alpha-L-iduronidase, leading to the accumulation of harmful substances in cells. This condition can lead to severe complications, including developmental delays, heart problems, and joint stiffness. There are three main forms of MPS I: Hurler syndrome, Hurler-Scheie syndrome, and...0 Komen 0 Perkongsian 529 Views 0 review
-
Advancing Mucopolysaccharidosis Type I Treatment — 4 Potential Therapies That Could Change the LandscapeMucopolysaccharidosis Type I (MPS I) is a rare and complex genetic disorder, resulting from a deficiency of the enzyme alpha-L-iduronidase, which leads to the accumulation of glycosaminoglycans (GAGs) in cells. This buildup can severely affect various organs, including the heart, liver, and brain. While existing treatments like enzyme replacement therapy (ERT) and hematopoietic stem cell...0 Komen 0 Perkongsian 448 Views 0 review
-
Transforming Obesity Care: The Cutting-Edge Solutions for 2025Obesity remains a major global health crisis, contributing to numerous chronic diseases such as diabetes, heart disease, and various cancers. But thanks to ongoing research and technological advancements, The Latest Breakthroughs in Obesity Treatment: A New Era of Weight Loss Innovation are paving the way for more effective and sustainable solutions in 2025. In the past few years, new...0 Komen 0 Perkongsian 380 Views 0 review
-
Exciting Breakthroughs in Multiple Myeloma Treatment: A Glimpse Into the FutureMultiple myeloma, an incurable yet treatable cancer affecting the bone marrow’s plasma cells, has seen remarkable progress in its treatment options. The recent treatment landscape for multiple myeloma is marked by innovative therapies, including new drug classes, immune-based treatments, and cutting-edge cell therapies. The emerging pipeline for multiple myeloma has brought forth a...0 Komen 0 Perkongsian 373 Views 0 review
-
The Weight of the World: Confronting the Obesity ChallengeHow Obesity is AssessedThe Body Mass Index (BMI) is the most widely used method for identifying obesity, calculated by dividing a person's weight by the square of their height. A BMI of 30 or higher signals obesity. While it doesn’t directly measure fat, it is a useful and accessible indicator of potential health risks related to excessive weight. Why Obesity is a Public Health...0 Komen 0 Perkongsian 398 Views 0 review
-
The Growing Weight Loss and Obesity Management Industry: Key Trends and InnovationsThe weight loss and obesity management industry is undergoing significant growth, driven by the increasing demand for effective solutions to address the global obesity epidemic. As the awareness of the health risks associated with obesity rises, more individuals are seeking products and services that can help them manage their weight. This growing demand is reflected in the expansion of...0 Komen 0 Perkongsian 402 Views 0 review
-
Revolutionizing Oncology: How the Liquid Biopsy Market Is Reshaping Cancer CareIntroduction The Liquid Biopsy Market is revolutionizing how cancer is detected, diagnosed, and managed. This non-invasive diagnostic approach, through the analysis of blood or other fluids, offers a real-time, patient-friendly alternative to traditional biopsies. With its rise, oncologists now have access to a tool that supports earlier detection, treatment personalization, and...0 Komen 0 Perkongsian 470 Views 0 review
-
Exploring the Expanding EGFR Inhibitor Market and Its Future PotentialThe healthcare industry is seeing a rapid rise in the adoption of precision medicine, with EGFR inhibitors leading the charge in targeted cancer treatments. The EGFR Inhibitor Market has become an essential part of cancer therapy, especially for patients suffering from non-small cell lung cancer (NSCLC), colorectal cancer, and other EGFR-driven tumors. These inhibitors block the action...0 Komen 0 Perkongsian 619 Views 0 review
-
Advancements in Hemophilia B: DelveInsight’s In-Depth AnalysisHemophilia B, or Christmas disease, results from a deficiency of clotting factor IX and affects a smaller patient population than Hemophilia A. Yet, innovations in care are transforming outcomes worldwide. This overview—Hemophilia B Market: A Comprehensive Overview by DelveInsight—examines current trends, leading players, and tomorrow’s breakthroughs. Market...0 Komen 0 Perkongsian 435 Views 0 review
Daha Hikayeler